Palisade Bio (PALI) Shares Outstanding (2010 - 2026)
Palisade Bio's (PALI) quarterly Shares Outstanding (Entity) came in at $488.0 in Q4 2019, up 190.48% year-on-year from $168.0 in Q4 2018, and down 22.04% on a QoQ basis from $626.0 in Q3 2019.
Palisade Bio (PALI) Shares Outstanding (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 10 years of Shares Outstanding (Entity) data on file, last reported at $488.0 in Q4 2019.
- On a quarterly basis, Shares Outstanding (Entity) rose 190.48% year-over-year to $488.0 in Q4 2019; TTM through Dec 2019 was $488.0, a 190.48% increase from a year earlier, with the FY2019 full-year figure at $488.0, up 190.48% from the prior year.
- Shares Outstanding (Entity) for Q4 2019 stood at $488.0, down from $626.0 in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for PALI reached as high as $626.0 in Q3 2019 and fell as low as $77.0 in Q1 2015.
- Historically, Shares Outstanding (Entity) has averaged $174.5 across 5 years, with a median of $150.5 in 2017.
- Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2018 and surged 270.41% in 2019, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $79.0 in 2015, then increased by 17.72% to $93.0 in 2016, then surged by 80.65% to $168.0 in 2017, then changed by 0.0% to $168.0 in 2018, then jumped by 190.48% to $488.0 in 2019.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $488.0 in Q4 2019, $626.0 in Q3 2019, and $223.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 209.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.66 Mn |
| Dec 31, 2025 | 55.67 Mn |
| Sep 30, 2025 | 7.47 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 768,137.00 |
| Dec 31, 2023 | 456,037.00 |
| Sep 30, 2023 | 489,648.00 |
| Jun 30, 2023 | 427,883.00 |
| Mar 31, 2023 | 287,716.00 |
| Dec 31, 2022 | 58,690.00 |
| Sep 30, 2022 | 64,950.00 |
| Jun 30, 2022 | 27,061.00 |
| Mar 31, 2022 | 21,633.00 |
| Dec 31, 2021 | 12,414.00 |
| Sep 30, 2021 | 16,135.00 |
| Jun 30, 2021 | 11,776.00 |